ROMIPLOSTIM N01
Clinical trials for ROMIPLOSTIM N01 explained in plain language.
Never miss a new study
Get alerted when new ROMIPLOSTIM N01 trials appear
Sign up with your email to follow new studies for ROMIPLOSTIM N01, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with Hard-to-Treat bleeding disorder
Disease control Not yet recruitingThis study tests a drug called romiplostim in 100 children aged 1 to 18 with chronic ITP, a condition where the immune system destroys platelets, causing bleeding. The drug aims to safely increase platelet counts to safe levels for at least 6 weeks out of 48, without needing resc…
Matched conditions: ROMIPLOSTIM N01
Sponsor: Assiut University • Aim: Disease control
Last updated May 17, 2026 08:14 UTC
-
New shot aims to fix chemo side effect in breast cancer patients
Symptom relief Not yet recruitingThis study tests a drug called romiplostim N01 in 68 breast cancer patients whose platelet counts dropped too low due to chemotherapy. The goal is to see if a weekly shot can safely bring platelet levels back up within two weeks, allowing patients to continue their cancer treatme…
Matched conditions: ROMIPLOSTIM N01
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC